Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Лечебное дело
2019 / N 4

Особенности течения артериальной гипертонии у больных с осложненным течением атеросклероза артерий нижних конечностей
Н.В. Теплова, В.И. Вечорко, Е.М. Евсиков, М.Х. Жапуева, Г.А. Червякова

Список литературы

1. Guidelines for the management of patients with peripheral arterial disease, management of Peripheral Arterial Disease (PAD). Trans Atlantic Inter-Society Consensus (TASC) 2007. Journal of Vascular Surgery 2007 Jan;45(Suppl):S5-67.
2. The TASC Steering Committee, Jaff MR, White CJ, Hiatt WR, Fowkes GR, Dormandy J, Razavi M, Reekers J, Norgren L. An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Journal of Endovascular Therapy 2015 Aug;22(5):657-71.
3. European Stroke Organisation, Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clément D, Collet JP, Cremonesi A, De Carlo M, Erbel R, Fowkes FG, Heras M, Kownator S, Minar E, Ostergren J, Poldermans D, Riambau V, Roffi M, Röther J, Sievert H, van Sambeek M, Zeller T; ESC Committee for Practice Guidelines. Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). The European Heart Journal 2011 Nov;32(22):2851-906.
4. Cremonesi A, Diehm N, Stella A, Gargiulo M, Faggioli G, de Campos Martins EC, Castriota F. Некоронарный атеросклероз. Атеросклероз сосудов нижних конечностей. В кн.: Болезни сердца и сосудов. Руководство Европейского общества кардиологов. Под ред. Кэмма А.Д., Люшера Т.Ф., Серруиса П.В. Пер.с англ. М.: Гэотар-Медиа; 2011: Гл. 36.
5. Атеросклероз, артериосклероз и поражение периферических артерий. Рекомендации по лечению артериальной гипертонии. ESH/ESC 2013.Рабочая группа по лечению артериальной гипертонии Европейского Общества Гипертонии (European Society of Hypertension, ESH) и Европейского Общества Кардиологов (European Society of Cardiology, ESC). Российский кардиологический журнал 2014;1(105):65-6.
6. Евсиков Е.М., Теплова Н.В., Майтесян Д.А., Шарипов Р.А., Левчук Н.Н., Каширин В.В., Червякова Г.А. Характер артериальной гипертензии у больных атеросклерозом аорты с синдромом острой тромботической окклюзии. Кардиология 2017;10:89-91.
7. Вечорко В.И., Теплова Н.В., Евсиков Е.М., Майтесян Д.А. Частота и причины артериальной гипертензии у больных с острой тромботической окклюзией при атеросклерозе артерий нижних конечностей. В сб.: Материалы XIII Национального конгресса терапевтов. Москва, 21-23 ноября 2018. М., 2018: 28-9.
8. Теплова Н.В. Вазилип в лечении атеросклероза и гипертензий. Российский медицинский журнал 2005;2:94-6.
9. Теплова Н.В., Люсов В.А., Оганов Р.Г., Евсиков Е.М. Нефрогенные факторы формирования резистентности к гипотензивной терапии у больных первичной артериальной гипертензией. Рациональная фармакотерапия в кардиологии 2015;6:590-4.
10. Евсиков Е.М., Теплова Н.В., Шарипов Р.А., Жапова М.Х., Курумлиду Е.Г. Характер патологии почек у больных артериальной гипертензией резистентного к терапии течения. В сб.: Тезисы Х Национального конгресса терапевтов. Москва, 14-16 октября 2015. М.: КСТ Интерфорум: 62.
11. Теплова Н.В. Резистентные формы первичной артериальной гипертензии. Патогенез, диагностика, лечение: руководство для врачей. М.: Литтерра; 2016. 110 с.
12. Теплова Н.В., Люсов В.А., Оганов Р.Г., Евсиков Е.М. Резистентность к гипотензивной терапии у больных гипертонической болезнью. Значение почечных и гемодинамических факторов. Уральский медицинский журнал 2015;10:126-32.
13. Теплова Н.В., Люсов В.А., Оганов Р.Г., Евсиков Е.М. Формы резистентности к гипотензивной терапии у больных первичной артериальной гипертензией. Уральский научный вестник 2015;12:20-30.
14. Теплова Н.В., Евсиков Е.М. Состояние гормональной функции и формы патологии щитовидной железы у больных первичной артериальной гипертензией и резистентностью к гипотензивной терапии. Сборник тезисов Российского национального конгресса кардиологов. М., 2015. 611 c.
15. Writing Committee Members, Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FGR, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin JW, Patel RAG, Regensteiner JG, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D, Walsh ME; ACC/AHA Task Force Members, Halperin JL, Levine GN, Al-Khatib SM, Birtcher KK, Bozkurt B, Brindis RG, Cigarroa JE, Curtis LH, Fleisher LA, Gentile F, Gidding S, Hlatky MA, Ikonomidis J Joglar J, Pressler SJ, Wijeysundera DN. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary. Vascular Medicine (London, England) 2017 Jun;22(3):NP1-NP43.
16. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009 May;338:b1665.
17. Sigvant B, Wiberg-Hedman K, Bergqist D, Rolandsson O, Andersson B, Persson E, Wablberg E. A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. Journal of Vascular Surgery 2007 Jun;45(6):1185-91.
18. Brevetti J, Oliva G, Silvestro A, Scopacasa F, Chiariello M; Peripheral Arteriopathy and Cardiovascular Events (PACE) Study Group. Prevalence, risk factors and cardiovascular comorbidity of symptomatic peripheral arterial disease in Italy. Atherosclerosis 2004 Jul;175(1):131-8.
19. Ankle Brachial Index Collaboration, Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, Folsom AR, Hirsch AT, Dramaix M, deBacker G, Wautrecht JC, Kornitzer M, Newman AB, Cushman M, Sutton-Tyrrell K, Fowkes FG, Lee AJ, Price JF, d’Agostino RB, Murabito JM, Norman PE, Jamrozik K, Curb JD, Masaki KH, Rodríguez BL, Dekker JM, Bouter LM, Heine RJ, Nijpels G, Stehouwer CD, Ferrucci L, McDermott MM, Stoffers HE, Hooi JD, Knottnerus JA, Ogren M, Hedblad B, Witteman JC, Breteler MM, Hunink MG, Hofman A, Criqui MH, Langer RD, Fronek A, Hiatt WR, Hamman R, Resnick HE, Guralnik J, McDermott MM. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008 Jul;300(2):197-208.
20. Gouveri E, Papanas N, Marakomichelakis G, Tzavara C, Drakopanagiotakis F, Maltezos E, Diamantopoulos EJ. Post-exercise ankle-brachial index is not an indispensable tool for the detection of peripheral arterial disease in an epidemiological survey. A post-hoc analysis of the Athens Study. International Angiology 2013 Oct;32(5):518-25.
21. Diehm C, Lange S, Darius H, Pittrow D, von Stritzky B, Tepohl G, Haberl RL, Allenberg JR, Dash B, Trampish HJ. Association of low ankle brachial index with high mortality in primary care. European Heart Journal 2006 Jul;27(14):1743-9.
22. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM Jr, White CJ, White J, White RA, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B; American Association for Vascular Surgery; Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC/AHA Task Force on Practice Guidelines; American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; Vascular Disease Foundation. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Journal of American College of Cardiology 2006 Mar;47(6):1239-312.
23. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O’Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008 Jan;117(4):e25-146.
24. Dachun Xu, Jue Li, Liling Zou, Yawei Xu, Dayi Hu, Pagoto SL, Yunsheng Ma. Sensitivity and specificity of the ankle-brachial index to diagnose peripheral artery disease: a structured review. Vascular Medicine (London, England) 2010 Oct;15(5):361-9.
25. Diehm C, Schuster A, Allenberg JR, Darius H, Haberl R, Lange S, Pittrow D, von Stritzky B, Tepohl G, Trampisch HJ. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 2004 Jan;172(1):95-105.
26. Ankle Brachial Index Collaboration, Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, Folsom AR, Hirsch AT, Dramaix M, de Backer G, Wautrecht JC, Kornitzer M, Newman AB, Cushman M, Sutton-Tyrrell K, Fowkes FG, Lee AJ, Price JF, d’Agostino RB, Murabito JM, Norman PE, Jamrozik K, Curb JD, Masaki KH, Rodríguez BL, Dekker JM, Bouter LM, Heine RJ, Nijpels G, Stehouwer CD, Ferrucci L, McDermott MM, Stoffers HE, Hooi JD, Knottnerus JA, Ogren M, Hedblad B, Witteman JC, Breteler MM, Hunink MG, Hofman A, Criqui MH, Langer RD, Fronek A, Hiatt WR, Hamman R, Resnick HE, Guralnik J, McDermott MM. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and cardiovascular events and mortality: a meta-analysis. JAMA 2008 Jul;300(2):197-208.
27. De Buyzere ML, Clement DL. Management of hypertension in peripheral arterial disease. Progress in Cardiovascular Diseases 2008;50:238-63.
28. Schröder F, Diehm N, Kareem S, Ames M, Pira A, Zwettler U, Lawall H, Diehm C. A modified calculation of ankle-brachial pressure index is far more sensitive in the detection of peripheral arterial disease. Journal of Vascular Surgery 2006 Sep;44(3):531-6.
29. Wassel CL, Allison MA, Ix JH, Rifkin DE, Forbang NI, Denenberg JO, Criqui MH. Ankle-brachial index predicts change over time in functional status in the San Diego Population Study. Journal of Vascular Surgery 2016 Sep;64(3):656-62.e1.
30. Feringa HH, BaxJJ, van Waning VH, Boersma E, Elhendy A, Schouten O, Tangelder MJ, van Sambeek MH, van den Meiracker AH, Poldermans D. The long term prognostic value of the resting and post-exercise ankle-brachial index. Archives of Internal Medicine 2006 Mar;166(5):529-35.
31. Mueller T, Hinterreiter F, Poelz W, Haltmayer M, Dieplinger B. Mortality rates at 10 years are higher in diabetic than in non-diabetic patients with chronic lower extremity peripheral arterial disease. Vascular Medicine (London, England) 2016 Oct;21(5):445-52.
32. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Journal of Vascular Surgery 2007 Jan;45(Suppl S):S5-67.
33. Dick F, Diehm N, Galimanis A, Husmann M, Schmidli J, Baumgartner I. Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome. Journal of Vascular Surgery 2007 Apr;45(4):751-61.
34. Fowkes FG, Forster RB, Levin CE, Naidoo NG, Roy A, Shu C, Spertus J, Fang K, Bechara-Zamudio L, Catalano M, Visonà A, Nikol S, Fletcher JP, Jaff MR, Hiatt WR, Norgren L. Prioritization of treatments for lower extremity peripheral artery disease in low- and middle-income countries. International Angiology 2017 Jun;36(3):203-15.
35. Singer DR, Kite A. Management of hypertension in peripheral arterial disease: does the choice of drugs matter? European Journal of Vascular and Endovascular Surgery 2008 Jun;35(6):701-8.
36. Imori Y, Akasaka T, Ochiai T, Oyama K, Tobita K, Shishido K, Nomura Y, Yamanaka F, Sugitatsu K, Okamura N, Mizuno S, Arima K, Suenaga H, Murakami M, Tanaka Y, Matsumi J, Takahashi S, Tanaka S, Takeshita S, Saito S. Co-existence of carotid artery disease, renal artery stenosis, and lower extremity peripheral arterial disease in patients with coronary artery disease. The American Journal of Cardiology 2014 Jan;113(1):30-5.
37. Özyilmaz A, de Jong PE, Gansevoort RT. Screening for chronic kidney disease can be of help to prevent atherosclerotic end-organ damage. Nephrology, Dialysis, Transplantation 2012 Nov;27(11):4046-52.
38. Bates MC, Campbell JE, Stone PA, Jaff MR, Brose M, Lavigne PS. Factors affecting long-term survival following renal artery stenting. Catheterization and Cardiovascular Intervention 2007 Jun;69(7):1037-43.
39. Safian RD, Textor SC. Renal-artery stenosis. The New England Journal of Medicine 2001 Feb;344(6):431-42.
40. Agel RA, Zoghbi GJ, Baldwin SA, Auda WS, Calhoun DA, Coffey CS, Perry GJ, Iskandrian AE. Prevalence of renal artery stenosis in high-risk veterans referred to cardiac catheterization. Journal of Hypertension 2003 Jun;21(6):1157-62.
41. Резистентная артериальная гипертензия: диагностика и тактика лечения. Артериальная гипертензия 2008;14(3):187-202.
42. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, Golden SH. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Annals of Internal Medicine 2004 Sep;141(6):421-31.

References

1. Guidelines for the management of patients with peripheral arterial disease, management of Peripheral Arterial Disease (PAD). Trans Atlantic Inter-Society Consensus (TASC) 2007. Journal of Vascular Surgery 2007 Jan; 45(Suppl):S5-67.
2. The TASC Steering Committee, Jaff MR, White CJ, Hiatt WR, Fowkes GR, Dormandy J, Razavi M, Reekers J, Norgren L. An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Journal of Endovascular Therapy 2015 Aug;22(5):657-71.
3. European Stroke Organisation, Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clément D, Collet JP, Cremonesi A, De Carlo M, Erbel R, Fowkes FG, Heras M, Kownator S, Minar E, Ostergren J, Poldermans D, Riambau V, Roffi M, Röther J, Sievert H, van Sambeek M, Zeller T; ESC Committee for Practice Guidelines. Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). The European Heart Journal 2011 Nov;32(22):2851-906.
4. Cremonesi A, Dim N, Stella A, Gargiulo M, Fagioli G, de Campos Martins EC, Castriota F. Non-coronary atherosclerosis. Atherosclerosis of the extremities. In: Diseases of heart and blood vessels. Guidelines of the European Society of Cardiology. Camm AJ, Lüscher TF, Serruys PW, editors. Moscow: Geotar-Media; 2011: Ch. 36 (In Russian).
5. 2013 ESH/ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Russian Journal of Cardiology 2014;1(105):65-6 (In Russian).
6. Yevsikov EM, Teplova NV, Maytesyan DA, Sharipov RA, Levchuk NN, Kashirin VV, Chervyakova GA. Arterial hypertension in patients with aortic atherosclerosis with acute thrombotic occlusion syndrome. Kardiologiia 2017;10:89-91 (In Russian).
7. Vechorko V, Teplova NV, Yevsikov EM, Maytesyan DA. Frequency and causes of arterial hypertension in patients with acute thrombotic occlusion in lower limb arterial atherosclerosis. In: Collection of materials of the XIII National Congress of Therapists; Moscow, Russia; 2018 Nov 21-23: 28-9 (In Russian).
8. Teplova NV. Vasilip in treatment of atherosclerosis and hypertension. Russian Medical Journal 2005;2:94-6 (In Russian).
9. Teplova NV, Lyusov VA, Oganov RG, Yevsikov EM. Neurogenic factors of resistance formation to hypotensive therapy in patients with primary arterial hypertension. Rational Pharmacotherapy in Cardiology 2015;6:590-4 (In Russian).
10. Yevsikov EM, Teplova NV, Sharipov RA, Zhapova MH, Kurumlidu EG. Kidney pathology in patients with arterial hypertension resistant to therapy. In: Collection of theses of X National Congress of Therapists; Moscow, Russia; 2015 Oct 14-16. Moscow: KST Interforum: 62 (In Russian).
11. Teplova NV. Resistant forms of primary arterial hypertension. Pathogenesis, diagnosis, treatment: guidelines for physicians. Moscow: Litterra; 2016. 110 p. (In Russian).
12. Teplova NV, Lyusov VA, Oganov RG, Yevsikov EM. Resistance to hypotensive therapy in patients with hypertension: renal and hemodynamic factors. Ural Medical Journal 2015;10:126-32 (In Russian).
13. Teplova NV, Lyusov VA, Oganov RG, Yevsikov EM. Forms of resistance to hypotensive therapy in patients with primary arterial hypertension. Ural Scientific Bulletin 2015;12:20-30 (In Russian).
14. Teplova NV, Yevsikov EM. Hormonal function and thyroid pathology in patients with primary hypertension and resistance to hypotensive therapy. Abstracts of the Russian National Congress of Cardiologists. Moscow, 2015. 611 p. (In Russian).
15. Writing Committee Members, Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FGR, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin JW, Patel RAG, Regensteiner JG, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D, Walsh ME; ACC/AHA Task Force Members, Halperin JL, Levine GN, Al-Khatib SM, Birtcher KK, Bozkurt B, Brindis RG, Cigarroa JE, Curtis LH, Fleisher LA, Gentile F, Gidding S, Hlatky MA, Ikonomidis J Joglar J, Pressler SJ, Wijeysundera DN. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary. Vascular Medicine (London, England) 2017 Jun;22(3):NP1-NP43.
16. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009 May;338:b1665.
17. Sigvant B, Wiberg-Hedman K, Bergqist D, Rolandsson O, Andersson B, Persson E, Wablberg E. A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. Journal of Vascular Surgery 2007 Jun;45(6):1185-91.
18. Brevetti J, Oliva G, Silvestro A, Scopacasa F, Chiariello M; Peripheral Arteriopathy and Cardiovascular Events (PACE) Study Group. Prevalence, risk factors and cardiovascular comorbidity of symptomatic peripheral arterial disease in Italy. Atherosclerosis 2004 Jul;175(1):131-8.
19. Ankle Brachial Index Collaboration, Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, Folsom AR, Hirsch AT, Dramaix M, de Backer G, Wautrecht JC, Kornitzer M, Newman AB, Cushman M, Sutton-Tyrrell K, Fowkes FG, Lee AJ, Price JF, d’Agostino RB, Murabito JM, Norman PE, Jamrozik K, Curb JD, Masaki KH, Rodríguez BL, Dekker JM, Bouter LM, Heine RJ, Nijpels G, Stehouwer CD, Ferrucci L, McDermott MM, Stoffers HE, Hooi JD, Knottnerus JA, Ogren M, Hedblad B, Witteman JC, Breteler MM, Hunink MG, Hofman A, Criqui MH, Langer RD, Fronek A, Hiatt WR, Hamman R, Resnick HE, Guralnik J, McDermott MM. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008 Jul;300(2):197-208.
20. Gouveri E, Papanas N, Marakomichelakis G, Tzavara C, Drakopanagiotakis F, Maltezos E, Diamantopoulos EJ. Post-exercise ankle-brachial index is not an indispensable tool for the detection of peripheral arterial disease in an epidemiological survey. A post-hoc analysis of the Athens Study. International Angiology 2013 Oct;32(5):518-25.
21. Diehm C, Lange S, Darius H, Pittrow D, von Stritzky B, Tepohl G, Haberl RL, Allenberg JR, Dash B, Trampish HJ. Association of low ankle brachial index with high mortality in primary care. European Heart Journal 2006 Jul;27(14):1743-9.
22. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM Jr, White CJ, White J, White RA, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B; American Association for Vascular Surgery; Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC/AHA Task Force on Practice Guidelines; American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; Vascular Disease Foundation. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Journal of American College of Cardiology 2006 Mar;47(6):1239-312.
23. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O’Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008 Jan;117(4):e25-146.
24. Dachun Xu, Jue Li, Liling Zou, Yawei Xu, Dayi Hu, Pagoto SL, Yunsheng Ma. Sensitivity and specificity of the ankle-brachial index to diagnose peripheral artery disease: a structured review. Vascular Medicine (London, England) 2010 Oct;15(5):361-9.
25. Diehm C, Schuster A, Allenberg JR, Darius H, Haberl R, Lange S, Pittrow D, von Stritzky B, Tepohl G, Trampisch HJ. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 2004 Jan;172(1):95-105.
26. Ankle Brachial Index Collaboration, Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, Folsom AR, Hirsch AT, Dramaix M, de Backer G, Wautrecht JC, Kornitzer M, Newman AB, Cushman M, Sutton-Tyrrell K, Fowkes FG, Lee AJ, Price JF, d’Agostino RB, Murabito JM, Norman PE, Jamrozik K, Curb JD, Masaki KH, Rodríguez BL, Dekker JM, Bouter LM, Heine RJ, Nijpels G, Stehouwer CD, Ferrucci L, McDermott MM, Stoffers HE, Hooi JD, Knottnerus JA, Ogren M, Hedblad B, Witteman JC, Breteler MM, Hunink MG, Hofman A, Criqui MH, Langer RD, Fronek A, Hiatt WR, Hamman R, Resnick HE, Guralnik J, McDermott MM. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and cardiovascular events and mortality: a meta-analysis. JAMA 2008 Jul;300(2):197-208.
27. De Buyzere ML, Clement DL. Management of hypertension in peripheral arterial disease. Progress in Cardiovascular Diseases 2008;50:238-63.
28. Schröder F, Diehm N, Kareem S, Ames M, Pira A, Zwettler U, Lawall H, Diehm C. A modified calculation of ankle-brachial pressure index is far more sensitive in the detection of peripheral arterial disease. Journal of Vascular Surgery 2006 Sep;44(3):531-6.
29. Wassel CL, Allison MA, Ix JH, Rifkin DE, Forbang NI, Denenberg JO, Criqui MH. Ankle-brachial index predicts change over time in functional status in the San Diego Population Study. Journal of Vascular Surgery 2016 Sep;64(3):656-62.e1.
30. Feringa HH, BaxJJ, van Waning VH, Boersma E, Elhendy A, Schouten O, Tangelder MJ, van Sambeek MH, van den Meiracker AH, Poldermans D. The long term prognostic value of the resting and post-exercise ankle-brachial index. Archives of Internal Medicine 2006 Mar;166(5):529-35.
31. Mueller T, Hinterreiter F, Poelz W, Haltmayer M, Dieplinger B. Mortality rates at 10 years are higher in diabetic than in non-diabetic patients with chronic lower extremity peripheral arterial disease. Vascular Medicine (London, England) 2016 Oct;21(5):445-52.
32. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Journal of Vascular Surgery 2007 Jan;45(Suppl S):S5-67.
33. Dick F, Diehm N, Galimanis A, Husmann M, Schmidli J, Baumgartner I. Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome. Journal of Vascular Surgery 2007 Apr;45(4):751-61.
34. Fowkes FG, Forster RB, Levin CE, Naidoo NG, Roy A, Shu C, Spertus J, Fang K, Bechara-Zamudio L, Catalano M, Visonà A, Nikol S, Fletcher JP, Jaff MR, Hiatt WR, Norgren L. Prioritization of treatments for lower extremity peripheral artery disease in low- and middle-income countries. International Angiology 2017 Jun;36(3):203-15.
35. Singer DR, Kite A. Management of hypertension in peripheral arterial disease: does the choice of drugs matter? European Journal of Vascular and Endovascular Surgery 2008 Jun;35(6):701-8.
36. Imori Y, Akasaka T, Ochiai T, Oyama K, Tobita K, Shishido K, Nomura Y, Yamanaka F, Sugitatsu K, Okamura N, Mizuno S, Arima K, Suenaga H, Murakami M, Tanaka Y, Matsumi J, Takahashi S, Tanaka S, Takeshita S, Saito S. Co-existence of carotid artery disease, renal artery stenosis, and lower extremity peripheral arterial disease in patients with coronary artery disease. The American Journal of Cardiology 2014 Jan;113(1):30-5.
37. Özyilmaz A, de Jong PE, Gansevoort RT. Screening for chronic kidney disease can be of help to prevent atherosclerotic end-organ damage. Nephrology, Dialysis, Transplantation 2012 Nov;27(11):4046-52.
38. Bates MC, Campbell JE, Stone PA, Jaff MR, Brose M, Lavigne PS. Factors affecting long-term survival following renal artery stenting. Catheterization and Cardiovascular Intervention 2007 Jun;69(7):1037-43.
39. Safian RD, Textor SC. Renal-artery stenosis. The New England Journal of Medicine 2001 Feb;344(6):431-42.
40. Agel RA, Zoghbi GJ, Baldwin SA, Auda WS, Calhoun DA, Coffey CS, Perry GJ, Iskandrian AE. Prevalence of renal artery stenosis in high-risk veterans referred to cardiac catheterization. Journal of Hypertension 2003 Jun;21(6):1157-62.
41. Resistant arterial hypertension: diagnostics and treatment tactics. Arterial Hypertension 200814(3):187-202 (In Russian).
42. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, Golden SH. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Annals of Internal Medicine 2004 Sep;141(6):421-31.
  

[ Содержание выпуска N 4 | Выпуски журнала | Список журналов ]